Close
GMP
FDA Academy
Downloadables
Bids and Awards
Careers
FAQs
Report
Contact Us
Menu
GMP
FDA Academy
Downloadables
Bids and Awards
Careers
FAQs
Report
Contact Us
Facebook
Search
Home
About FDA
Transparency
Issuances
Advisories
Administrative Order
Executive Order
FDA Circular
FDA Memorandum
Memorandum Circular
Republic Act
Old Issuances
Services
eServices
ePortal
ePortal2
Doctrack
RRDportal
Menu
Home
About FDA
Transparency
Issuances
Advisories
Administrative Order
Executive Order
FDA Circular
FDA Memorandum
Memorandum Circular
Republic Act
Old Issuances
Services
eServices
ePortal
ePortal2
Doctrack
RRDportal
Whole Virion, Inactivated Corona Virus Vaccine
[Covaxin]
On 21 June 2021, the Food and Drug Administration (FDA)
issued authorization granting IP BIOTECH, INC. the emergency use approval of Whole Virion, Inactivated Corona Virus Vaccine [Covaxin].
Product Information
English
Information on the safety of Whole Virion, Inactivated Corona Virus Vaccine [Covaxin] is discussed in their comprehensive Risk Management Plan.
For more information on reporting side effects, click
here
.
Shares